Item 8.01. Other Events.

On January 27, 2023, Jasper Therapeutics, Inc. (the "Company") issued a press release announcing the closing of its previously announced underwritten public offering of shares of its voting common stock, $0.0001 par value per share ("Common Stock"). In the offering, the Company sold an aggregate of 69,000,000 shares of Common Stock at a public offering price of $1.50 per share, which includes the exercise in full by the underwriters of their option to purchase 9,000,000 additional shares of Common Stock. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.





(d) Exhibits.



Number    Description
99.1        Press Release, dated January 27, 2023.
104       Cover Page Interactive Data File, formatted in Inline Extensible
          Business Reporting Language (iXBRL).




                                       1

© Edgar Online, source Glimpses